FGF19
FGF19 詳細
| 英語名 | Fibroblast growth factor 19 | 市販薬剤の数 | 0 |
| 治験薬の数 | 2 | ターゲットの別称 | FGF-19 |
| 研究＆開発段階 | Phase 2 Clinical | ||
| 英語名 | Fibroblast growth factor 19 |
| ターゲットの別称 | FGF-19 |
| 市販薬剤の数 | 0 |
| 治験薬の数 | 2 |
| 研究＆開発段階 | Phase 2 Clinical |
FGF19 製品リスト
- 属性
Protein (3)
- 製品ライブラリ
オンライン (3)
- 種
Human (3)
- タグ
Fc Tag (1)His Tag (1)Mouse IgG Fc Tag (1)
- マーカー
Unconjugated (3)
| 製品番号 | 種 | 発現システム | 製品説明 | タンパク質の構造 | 純度 | 特性 |
|---|---|---|---|---|---|---|
 Human | E. coli | Human FGF19 Protein, His Tag (BLI verified) |  |  |  | |
| Human | HEK293 | Human FGF19 Protein, Fc Tag |  | |  | |
| Human | HEK293 | Human FGF19 Protein, Mouse IgG2a Fc Tag |  | |
総数量3
- 1
FGF19バックグランド
Fibroblast growth factor (FGF)19 is the first members of a new subfamily of FGFs and could act as hormones. During fetal life, FGF15/19 is involved in organogenesis, affecting the development of the ear, eye, heart, and brain. FGFs–FGFRs are involved in regulation of many biological processes such as embryonic development, cell proliferation, differentiation, and tissue repair. The dysregulation of FGF–FGFR was observed in different types of diseases, disorders, and cancers. Notably, aberrant expression of FGF19/FGFR4 contributes to Hepatocellular Carcinoma progression.
FGF19分子の別称
FGF19,FGF-19,Fibroblast growth factor 19
治験薬に関する情報
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Aldafermin | M-70; NGM-282; M70; NGM282 | Phase 2 Clinical | NGM Biopharmaceuticals Inc | Bile acid malabsorption (BAM); Cholangitis, Sclerosing; Constipation; Diabetes Mellitus; Diarrhea; Fibrosis; Hepatic Insufficiency; Irritable Bowel Syndrome; Liver Cirrhosis, Biliary; Malabsorption Syndromes; Metabolic Dysfunction-Associated Steatotic Liver Disease; Renal Insufficiency | 詳細 |
| HH-009 | Phase 1 Clinical | Huahui Health Ltd | Neoplasms; Solid tumours | 詳細 |
レビュー
M***i2023-02-08
1評価Awesome.The product quality was good ,and great technical service and I received the product on time.
- 詳細
- 製品リスト
- レビュー
- 治験薬に関する情報